搜尋結果
Stocks making the biggest moves premarket: Gilead Sciences, Sarepta Therapeutics, Nike and more
CNBC· 21 小時前The decline comes after the AI chipmaker on Tuesday briefly topped Microsoft as the most ...
The termination of patent terminal disclaimers?
Reuters· 19 小時前The United States Patent and Trademark Office (USPTO) is proposing a rule change, that if ...
Inside Out 2 expands on teenage turmoil
China Daily· 6 小時前Despite a nine-year hiatus in the real world, Riley Andersen, the young protagonist of the franchise, ...
Khosla-backed Marble, built by former Headway founders, offers affordable group therapy for teens
TechCrunch· 19 小時前A recent report from the Center of Disease Control found that nearly one in three girls have ...
Neuralink competitor Paradromics gears up to test its brain implant on humans
CNBC· 22 小時前Neurotech startup Paradromics will be putting its brain implant on trial next year, as the race ...
Former Italy international Roberto Baggio robbed at gunpoint at home
Reuters· 23 小時前Burglars broke into Baggio's house near Vicenza, hit him on the head with a gun butt and ...
Painful deja vu as Slovakia punished by Ukraine
Reuters· 18 小時前Slovakia coach Francesco Calzona said there had been no celebrating after his side’s shock ...
Sarepta's Stock Soars on Best-Case FDA Decision for its Muscular Dystrophy Treatment
The Wall Street Journal· 19 小時前For biotech companies, regulatory approval is usually one of many steps needed to convince Wall ...